Children with Functional Nausea-Comorbidities outside the Gastrointestinal Tract

Sally E Tarbell1, Erin C Sullivan2, Carol Meegan2

  • 1Pritzker Department of Psychiatry and Behavioral Health, Ann and Robert H. Lurie Children's Hospital, Chicago, IL; Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, Chicago, IL.

Insights

Children with functional nausea often have multisystem conditions beyond the gut, such as anxiety and sleep issues. Extensive gastrointestinal testing rarely identifies a cause for their symptoms.

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology
  • Clinical Medicine

Background:

  • Functional nausea is a common yet complex condition in children.
  • Identifying comorbidities is crucial for understanding and managing pediatric functional nausea.

Purpose of the Study:

  • To identify common comorbidities in children with functional nausea.
  • To evaluate the diagnostic yield of procedures used to assess functional nausea.

Main Methods:

  • Prospective study of 63 children (age 7-18) meeting Rome IV criteria for functional nausea.
  • Utilized questionnaires (PROMIS-25, Sleep Disturbance, COMPASS 31) for comorbidity assessment.
  • Reviewed medical records for diagnostic tests and additional comorbidities.

Main Results:

  • Functional nausea patients frequently had multisystem comorbidities including abdominal pain, headache, anxiety, and sleep disturbances.
  • Good to excellent agreement was found between child and parent-proxy symptom reports.
  • Extensive gastrointestinal diagnostic testing (endoscopies, radiologic tests) yielded low diagnostic value.

Conclusions:

  • Children with functional nausea exhibit significant comorbidities outside the GI tract requiring evaluation.
  • Gastrointestinal diagnostic procedures have a low yield in determining the cause of functional nausea.
  • Understanding comorbidity relationships can inform etiology and tailor clinical care for pediatric functional nausea.
Abstract

Related Concept Videos

Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.4K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
954
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
443
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
513
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
684